Gene Expression Signature Differentiates Histology But Not Progression Status of Early-Stage NSCLC()

Advances in molecular analyses based on high-throughput technologies can contribute to a more accurate classification of non–small cell lung cancer (NSCLC), as well as a better prediction of both the disease course and the efficacy of targeted therapies. Here we set out to analyze whether global gen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Oncol
Main Authors: Charkiewicz, Radoslaw, Niklinski, Jacek, Claesen, Jürgen, Sulewska, Anetta, Kozlowski, Miroslaw, Michalska-Falkowska, Anna, Reszec, Joanna, Moniuszko, Marcin, Naumnik, Wojciech, Niklinska, Wieslawa
Formato: Artigo
Idioma:Inglês
Publicado em: Neoplasia Press 2017
Assuntos:
Original article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5408153/
https://ncbi.nlm.nih.gov/pubmed/28456114
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2017.01.015
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados